|
|
Effect of Gefitinib on Tumor Markers and Circulating Blood miR in Patients with Advanced Non-small Cell Lung Cancer with EGFR Mutation |
HUANG Sufang, HUANG Qiuling, WU Peifeng, LIU Limin |
First-author's address: Department of Pharmacy, 910th Hospital of Joint Logistics Support Force, Quanzhou 362000, China |
|
|
|
Received: 27 September 2024
|
|
|
|
|
|
|